|
AU6348398A
|
|
Syngeristic interplay of lymphokines and dsRNAs
|
|
AU6348498A
|
|
Double stranded RNA correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles
|
|
AU6199198A
|
|
Double-stranded RNA correction of abnormalities in circulating immune complexes and monocyte function
|
|
AU4849897A
|
|
Elaboration of Host Defense Mediators into Biological Fluids by Systemic dsRNA Treatment
|
|
AU4850097A
|
|
Topically active compositions of double-stranded RNAs
|
|
AU4849997A
|
|
Diagnosis and treatment of double stranded deficiency states
|
|
US5906980A
|
|
Treatment of hepatitis with mismatched dsRNA
|
|
US5712257A
|
|
Topically active compositions of mismatched dsRNAs
|
|
AU1761095A
|
|
Modulation of lymphokine-resistant cellular states by dsRNAs
|
|
AU1761295A
|
|
Synergistic interplay of lymphokines and dsRNAs
|
|
US6130206A
|
|
Treating viral infections associated with chronic fatigue with dsRNA
|
|
IL108227D0
|
|
In vitro method for diagnosis of chronic viral infection and viral-induced chronic fatigue syndrome
|
|
AU5254593A
|
|
Short therapeutic dsRNA of defined structure
|
|
IL103630D0
|
|
Topical pharmaceutical compositions comprising complexes of mismatched double-stranded rna stabilized with surface-active agents
|
|
AU1618592A
|
|
Modulation of lymphokine-resistant cellular states by dsrnas
|
|
CA2060490A1
|
|
Protection from shock subsequent to injury by double-stranded rnas
|
|
CA2060489A1
|
|
Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction
|
|
US5194245A
|
|
Diagnosis of viral hepatitis
|
|
BR9106503A
|
|
Diagnosis and treatment of viral hepatitis
|
|
US5091374A
|
|
Double-stranded RNA correction of abnormalities in circulating immune complexes and monocyte function
|
